Fortress Biotech
FBIO
52 hedge funds and large institutions have $21.8M invested in Fortress Biotech in 2016 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 10 closing their positions.
3,350% more call options, than puts
Call options by funds: $69K | Put options by funds: $2K
80% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 10
78% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 9
18% more funds holding
Funds holding: 44 → 52 (+8)
11% more capital invested
Capital invested by funds: $19.7M → $21.8M (+$2.14M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.52M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$962K |
| 3 |
State Street
Boston,
Massachusetts
|
+$797K |
| 4 |
Goldman Sachs
New York
|
+$666K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$552K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EM
Elliott Management
New York
|
-$1.12M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$235K |
| 3 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
-$186K |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$165K |
| 5 |
Morgan Stanley
New York
|
-$145K |
FBIO Hedge Fund Activity: Q2 2016 in Review
52 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q2 2016, worth a combined $21.8M — up 11% from $19.7M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new FBIO positions and 10 closed out — a net gain of 8 holders — while 16 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $2.52M. The largest seller was Elliott Management, cutting an estimated $1.12M.
- 52 institutional investors held Fortress Biotech (FBIO) as of Q2 2016, up from 44 in Q1 2016.
- Funds reported $21.8M of Fortress Biotech stock for Q2 2016, up 11% quarter-over-quarter.
- 18 funds opened new Fortress Biotech positions in Q2 2016 and 10 closed out, a net change of +8 holders.
- The largest Fortress Biotech buyer in Q2 2016 was BlackRock Fund Advisors, an estimated $2.52M added.
- The largest Fortress Biotech seller in Q2 2016 was Elliott Management, an estimated $1.12M sold.
Based on aggregated 13F filings for Q2 2016.